Atlas Trials

3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA

Clinical trial NCT02439788 · WITHDRAWN

Trial details

NCT number
NCT02439788
Sponsor
Baylor College of Medicine
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Neuroblastoma
Start date
2017-08-01
Primary completion
2019-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.